The reduction of FVIII-specific CD4+ T cell activation, as well as amplification of regulatory subsets of T cells by IDO1 represents a potential mechanism for tolerance induction and a possible strategic means to restrain the anti-FVIII immune response in hemophilia A. The gene discussed is IDO1; the disease is hemophilia A.